BROOKS WILEY: Open Payments
NPI 1003267923 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 40 payments from 16 companies in 2025. Trend: 2023 $683 · 2024 $711 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $102 |
| ABBVIE INC. | 5 | $98 |
| Lundbeck LLC | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Braeburn Inc. | 2 | $46 |
| Biogen, Inc. | 2 | $43 |
Products named: INGREZZA, VRAYLAR, REXULTI, FANAPT, Jornay PM, ABILIFY MAINTENA, AUSTEDO XR, BRIXADI.
Industry payments across UT — which companies pay providers there.
